Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies
- PMID: 29381912
- PMCID: PMC5708911
- DOI: 10.1097/MD.0000000000008230
Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies
Abstract
Background: Diabetes mellitus (DM) is inconsistently associated with thyroid cancer risk. The purpose of this study was to summarize findings from cohort studies regarding the strength of the association of DM with subsequent thyroid cancer risk.
Methods: Electronic searches were performed in PubMed, EmBase, and the Cochrane Library to identify studies from inception to July 2016. Cohort studies reporting risk estimates with 95% confidence intervals (CIs) of thyroid cancer in DM and non-DM patients were included. A random-effects meta-analysis was performed to the risk of thyroid cancer in DM compared with non-DM participants.
Results: Sixteen cohort studies were included, with a total of 10,725,884 individuals. These studies reported a total of 8032 cases of thyroid cancer. Overall, DM was associated with an increased risk of thyroid cancer (relative risk [RR], 1.20; 95% CI, 1.09-1.33; P < .001). Further, there was no significant difference was found between DM and non-DM for the risk of thyroid cancer in men (RR, 1.14; 95% CI, 1.00-1.30; P = .057), while a significant correlation was found in a pooled analysis in women (RR, 1.11; 95% CI, 1.06-1.17; P < .001). Finally, subgroup analyses suggested that country and mean age might correlate with the relationship between DM and the risk of thyroid cancer.
Conclusion: This study suggested that patients with DM have significantly increased risk of thyroid cancer compared nondiabetics. This positive association was prominent in women, and not significant in men. Further large-scale studies are required to verify the nature of the association, which should be evaluated in specific subpopulations.
Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures
Similar articles
-
Diabetes mellitus and risk of thyroid cancer: a meta-analysis.PLoS One. 2014 Jun 13;9(6):e98135. doi: 10.1371/journal.pone.0098135. eCollection 2014. PLoS One. 2014. PMID: 24927125 Free PMC article.
-
Different types of diabetes mellitus and risk of thyroid cancer: A meta-analysis of cohort studies.Front Endocrinol (Lausanne). 2022 Sep 23;13:971213. doi: 10.3389/fendo.2022.971213. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36213272 Free PMC article.
-
Association of diabetes mellitus with non-Hodgkin lymphoma risk: a meta-analysis of cohort studies.Hematology. 2019 Dec;24(1):527-532. doi: 10.1080/16078454.2019.1636485. Hematology. 2019. PMID: 31262228
-
Association between diabetes mellitus and lung cancer: Meta-analysis.Eur J Clin Invest. 2020 Oct;50(10):e13332. doi: 10.1111/eci.13332. Epub 2020 Jul 13. Eur J Clin Invest. 2020. PMID: 32589285
-
Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies.BMC Cancer. 2018 Apr 16;18(1):422. doi: 10.1186/s12885-018-4351-4. BMC Cancer. 2018. PMID: 29661174 Free PMC article.
Cited by
-
Comorbidity Risk Score in Association with Cancer Incidence: Results from a Cancer Screenee Cohort.Cancers (Basel). 2020 Jul 8;12(7):1834. doi: 10.3390/cancers12071834. Cancers (Basel). 2020. PMID: 32650429 Free PMC article.
-
Thyroid Dysfunction and Type 2 Diabetes Mellitus: Screening Strategies and Implications for Management.Diabetes Ther. 2019 Dec;10(6):2035-2044. doi: 10.1007/s13300-019-00700-4. Epub 2019 Oct 3. Diabetes Ther. 2019. PMID: 31583645 Free PMC article. Review.
-
Associations of Combined Exposure to Metabolic and Inflammatory Indicators with Thyroid Nodules in Adults: A Nested Case-Control Study.Int J Endocrinol. 2024 Mar 27;2024:3950894. doi: 10.1155/2024/3950894. eCollection 2024. Int J Endocrinol. 2024. PMID: 38571926 Free PMC article.
-
The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms.Front Endocrinol (Lausanne). 2022 Feb 11;13:800995. doi: 10.3389/fendo.2022.800995. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35222270 Free PMC article. Review.
-
Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer.Cancers (Basel). 2022 Jan 22;14(3):555. doi: 10.3390/cancers14030555. Cancers (Basel). 2022. PMID: 35158824 Free PMC article. Review.
References
-
- Ron E, Schneider AB. Schottenfeld D, Fraumeni JF., Jr Thyroid cancer. Cancer Epidemiology and Preventioned. New York: Oxford University Press; 2006. 975–94.
-
- Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2009;16:1251–60. - PubMed
-
- Radisauskas R, Kuzmickiene I, Milinaviciene E, et al. Hypertension, serum lipids and cancer risk: a review of epidemiological evidence. Medicina (Kaunas) 2016;52:89–98. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical